Penumbra is a medical device company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker PEN on the NYSE exchange.
Penumbra stock last closed at $206.62, down 2.24% from the previous day, and has increased 3.26% in one year. It has underperformed other stocks in the Medical Devices industry by 0.06 percentage points. Penumbra stock is currently +39.61% from its 52-week low of $148.00, and -25.5% from its 52-week high of $277.34.
As of Oct 15, 2024, there are 38.84M shares of PEN outstanding. The market capitalization of PEN is $8.03B. In the last 24 hours, 361,377 PEN shares were traded.
How to Buy Penumbra Stock
Wondering how to invest in Penumbra stock? Here's how.
Decide where to buy Penumbra stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you decide where to buy Penumbra stock.
Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Put funds into your investment account: Select your payment method and add your info.
Research Penumbra stock: The Penumbra ticker symbol is PEN. Is Penumbra stock a good investment? Should you buy shares of PEN? How do PEN's underlying business fundamentals look? Do top analysts think Penumbra is a good buy? Why has PEN's stock price moved recently? (Hint: Our stock research tools can help you figure out if PEN is a good stock to buy).
Execute your PEN buy order: Decide if you will purchase PEN shares at the current market price or use a limit order to buy PEN shares at a specific price.
Get the latest news on your PEN position: Create a watchlist to important notifications about your position in Penumbra stock.
Step 1: Decide where to buy Penumbra stock
You will need a brokerage account to access the NYSE market and buy PEN stock.
A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global financial markets: From Technology to Industrials, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've selected your brokerage, it's time to fill out some personal details so you can buy PEN stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Penumbra stock
After you have chosen the best place to buy Penumbra stock, it's crucial to evaluate their stock before you buy, so you actually wrap your head around the risk and opportunity.
Penumbra shares at a glance
PEN Price
$206.62
1w %
6.06%
1y %
3.26%
5y %
40.66%
P/E
543.74x
P/B
6.91x
P/S
7.07x
PEG
4.07x
Revenue
$1.13B
Earnings
$14.23M
Fore. Rev. Growth
11.65%
Fore. Earn. Growth
133.48%
Market Cap
$8.03B
Next Earnings
Oct 30, 2024
Next Dividend
N/A
Penumbra Zen Score
WallStreetZen was built to help part-time investors do better fundamental analysis in less time.
You can view all of the due diligence checks on PEN's stock page.
Is PEN stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PEN's intrinsic value.
Using relative valuations metrics:
PEN may be overvalued based on its P/E ratio of 543.74x, relative to Medical Devices industry P/E ratio of 41.26x
PEN could be overvalued based on its P/B ratio of 6.91x, relative to Medical Devices industry P/B ratio of 4.08x
PEN could be overvalued based on its PEG ratio of 4.07x
PEN's operating cash flow of $128.01M allows it to safely service it's debt of $228.82M.
PEN has a low debt to equity ratio of 0.32.
There are more short-term assets than short-term liabilities on the PEN balance sheet.
There are more short-term assets than long-term liabilities on the PEN balance sheet.
Signs that PEN is not financially healthy:
PEN earnings of -$11.79M is not sufficient to cover its interest payments.
Total PEN debt is higher than 5 years ago, relative to shareholder equity.
PEN profit margin has gone down from 3.1% to 1.3% in the past year.
Do Wall Street analysts think it's a good time to buy PEN stock
Out of 11 Equities analysts who give ratings on PEN, the consensus analyst rating on Penumbra is a Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent PEN Analyst Ratings
Joanne Wuensch, a top 8% analyst from Citigroup maintains PEN with a hold rating and raises their PEN price target from $178.00 to $200.00, on Aug 22, 2024.
David Rescott, a bottom 47% analyst from Baird maintains PEN with a buy rating and lowers their PEN price target from $231.00 to $180.00, on Jul 31, 2024.
Jason Mills, a top 4% analyst from Canaccord Genuity maintains PEN with a strong buy rating and lowers their PEN price target from $272.00 to $176.00, on Jul 31, 2024.
Larry Biegelsen, a top 10% analyst from Wells Fargo downgrades PEN to a hold rating and lowers their PEN price target from $289.00 to $150.00, on Jul 31, 2024.
Matthew O'Brien, a bottom 3% analyst from Piper Sandler maintains PEN with a strong buy rating and lowers their PEN price target from $260.00 to $200.00, on Jul 31, 2024.
Last year, PEN earnings were $14.23M. In the last five year, PEN's earnings have gone up by -2.44% per year. This was slower than the Medical Devices industry average of 9.16%.
Last year, PEN revenue was $1.13B. Over the past five year, PEN's revenue has increased by 18.01% per year. This was faster than the Medical Devices industry average of 10.98%.
No, Penumbra doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your PEN buy order
There are two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are mostly fine.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at an exact price limit, use a limit order.
Click the Open Trade button and your broker will place the order.
If you require additional assistance investing in stocks on eToro, click the how to video below:
As of Oct 15, 2024, it costs $206.62 to buy one share of Penumbra stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.484 shares of PEN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.